SDHA and neoplasm: We suggest especially radionuclide imaging three-four months after presumed complete resection of a metastatic/multiple PCC, any PGL, or high-risk (SDHA/B) mutation carrier in the case of post-operative abnormal biochemistry or non-functional tumor (Table 3).